Pure Extracts Signs Tolling Agreement for 500 kgs of CBD Rich Hemp
Pure Extracts Technologies Corp (CSE: PULL, OTC: PRXTF) announced a tolling agreement allowing the extraction of 80-85% pure CBD distillate from 500 kgs of hemp biomass. The biomass has a CBD potency exceeding 10%, ensuring efficient extraction using the company's Vitalis R200 CO2 system. The high purity of the distillate positions it as a prime ingredient for various consumer products. CEO Ben Nikolaevsky expressed satisfaction with the agreement and familiarity with the biomass, reinforcing confidence in the extraction process.
- Signed tolling agreement for extracting 80-85% pure CBD distillate.
- Utilizing 500 kgs of hemp biomass with over 10% CBD potency.
- High purity of distillate suitable for diverse product applications.
- None.
VANCOUVER, British Columbia., April 28, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has signed a tolling agreement for the extraction of 80
The biomass was sourced from one of Pure Extracts’ preferred suppliers and has a CBD potency of just over
The high level of purity in the extracted CBD distillate makes it an ideal ingredient for vape cartridges, topicals, beverages and edible gummies and chocolates.
Pure Extracts CEO, Ben Nikolaevsky, remarked, “We are pleased to have entered into this tolling agreement and to have taken delivery of the first 500 kg of milled hemp biomass. We are very familiar with this particular biomass having used it before in the manufacturing of our in-house, branded products, so we know it extracts very well.”
About Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ)
Pure Extracts features an all-new, state-of-the-art processing facility located just 20 minutes north of world-famous Whistler, British Columbia. The bespoke facility has been constructed to European Union GMP standards aiming towards export sales of products and formulations, including those currently restricted in Canada, into European jurisdictions where they are legally available. On September 25, 2020, Pure Extracts was granted its Standard Processing License by Health Canada under the Cannabis Act and the Company’s stock began trading on the Canadian Securities Exchange (CSE) on November 5, 2020. Find out more at https://pureextractscorp.com/.
For further information please contact Empire Communications Group at (604) 343-2724 and ir@empiregroupir.com.
ON BEHALF OF THE BOARD
“Ben Nikolaevsky”
Ben Nikolaevsky
CEO and Director
The CSE has neither approved nor disapproved the contents of this press release.
This news release contains forward-looking statements relating to the future operations of Pure Extracts,
and the other statements are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, including, without limitation, statements regarding the future plans and objectives of Pure Extracts’, are forward-looking statements and involve risks and uncertainties. A number of factors could cause actual events, performance or results to differ materially from what is projected in forward looking statements. Although we believe that the assumptions underlying these statements are reasonable, they may prove to be incorrect, and we cannot assure that actual results will be consistent with these forward-looking statements. Given these risks, uncertainties and assumptions, investors should not place undue reliance on these forward-looking statements. Whether actual results, performance or achievements will conform to the Company’s expectations and predictions is subject to a number of known and unknown risks, uncertainties, assumptions and other factors, including those listed under “Risk Factors” in the Company’s Annual Information Form. The Company does not undertake to update any forward-looking information, except as, and to the extent required by, applicable securities laws.
This news release contains information about potential sales revenue from supply agreements, which may be considered as disclosure of financial outlook under applicable securities laws. Such information is subject to the same assumptions, risk factors, limitations, and qualifications as set forth in the above paragraph. Specifically, estimated sales revenue which may be derived from supply contracts has been calculated based on current wholesale prices and assume, among other things, that the Company will be able to find buyers for its products. Financial outlook contained in this news release was made by management as of the date of this news release and was provided for the purpose of providing readers with an understanding of the potential revenue which may be derived from supply agreement recently entered into by the Company, and are not an estimate of profitability or any other measure of financial performance. Readers are cautioned that the financial outlook contained in this document should not be used for purposes other than for which it is disclosed herein.
FAQ
What is the latest press release from Pure Extracts Technologies Corp regarding CBD extraction?
What does the tolling agreement mean for Pure Extracts Technologies Corp's stock PRXTF?
What are the applications of the CBD distillate extracted by Pure Extracts?
How does the CBD potency of the biomass affect Pure Extracts Technologies Corp?
